|
KMID : 0352720210450030380
|
|
Journal of Ginseng Research
2021 Volume.45 No. 3 p.380 ~ p.389
|
|
|
Effect of Korean Red Ginseng on metabolic syndrome
|
|
Yoon Sang-Jun
Kim Seul-Ki
Lee Na-Young
Choi Ye-Rin
Kim Hyeong-Seob
Gupta Haripriya
Youn Gi-Soo
Sung Ho-Taik
Shin Min-Jea
Suk Ki-Tae
|
|
|
Abstract
|
|
|
|
Metabolic syndrome (MS) refers to a clustering of at least three of the following medical conditions: high blood pressure, abdominal obesity, hyperglycemia, low high-density lipoprotein level, and high serum triglycerides. MS is related to a wide range of diseases which includes obesity, diabetes, insulin resistance, cardiovascular disease, dyslipidemia, or non-alcoholic fatty liver disease. There remains an ongoing need for improved treatment strategies for MS. The most important risk factors are dietary pattern, genetics, old age, lack of exercise, disrupted biology, medication usage, and excessive alcohol consumption, but pathophysiology of MS has not been completely identified. Korean Red Ginseng (KRG) refers to steamed/dried ginseng, traditionally associated with beneficial effects such as anti-inflammation, anti-fatigue, anti-obesity, anti-oxidant, and anti-cancer effects. KRG has been often used in traditional medicine to treat multiple metabolic conditions. This paper summarizes the effects of KRG in MS and related diseases such as obesity, cardiovascular disease, insulin resistance, diabetes, dyslipidemia, or non-alcoholic fatty liver disease based on experimental research and clinical studies.
|
|
|
KEYWORD
|
|
|
Panax ginseng, Metabolic syndrome, Insulin resistance, Non-alcoholic fatty liver disease
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|